Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control.

Anton RF, Schacht JP, Voronin KE, Randall PK.

Alcohol Clin Exp Res. 2017 Jul;41(7):1370-1380. doi: 10.1111/acer.13417. Epub 2017 Jun 5.


Deficits in the extinction of ethanol-seeking behavior following chronic intermittent ethanol exposure are attenuated with positive allosteric modulation of mGlu5.

Gass JT, McGonigal JT, Chandler LJ.

Neuropharmacology. 2017 Feb;113(Pt A):198-205. doi: 10.1016/j.neuropharm.2016.10.005. Epub 2016 Oct 8.


A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.

Ryan ML, Falk DE, Fertig JB, Rendenbach-Mueller B, Katz DA, Tracy KA, Strain EC, Dunn KE, Kampman K, Mahoney E, Ciraulo DA, Sickles-Colaneri L, Ait-Daoud N, Johnson BA, Ransom J, Scott C, Koob GF, Litten RZ.

Neuropsychopharmacology. 2017 Apr;42(5):1012-1023. doi: 10.1038/npp.2016.214. Epub 2016 Sep 23.


Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Berlin RK, Butler PM, Perloff MD.

Prim Care Companion CNS Disord. 2015 Oct 22;17(5). doi: 10.4088/PCC.15r01821. eCollection 2015.


Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Yardley MM, Ray LA.

Addict Biol. 2017 May;22(3):581-615. doi: 10.1111/adb.12349. Epub 2016 Feb 1.


Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats.

Besheer J, Frisbee S, Randall PA, Jaramillo AA, Masciello M.

Neuropharmacology. 2016 Feb;101:216-24. doi: 10.1016/j.neuropharm.2015.09.027. Epub 2015 Sep 28.


Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment.

Wackernah RC, Minnick MJ, Clapp P.

Subst Abuse Rehabil. 2014 Jan 23;5:1-12. doi: 10.2147/SAR.S37907. eCollection 2014. Review.


Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex.

Trantham-Davidson H, Burnett EJ, Gass JT, Lopez MF, Mulholland PJ, Centanni SW, Floresco SB, Chandler LJ.

J Neurosci. 2014 Mar 5;34(10):3706-18. doi: 10.1523/JNEUROSCI.0623-13.2014. Erratum in: J Neurosci. 2014 Apr 30;34(18):6422.


A case of Zolpidem dependence successfully detoxified with gabapentin.

Fernandes WH, Pereira Yda S, O' Tereza S.

Indian J Psychiatry. 2013 Jul;55(3):290-2. doi: 10.4103/0019-5545.117152.


Alcohol dependence, withdrawal, and relapse.

Becker HC.

Alcohol Res Health. 2008;31(4):348-61. Review.


Glutamatergic medications for the treatment of drug and behavioral addictions.

Olive MF, Cleva RM, Kalivas PW, Malcolm RJ.

Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Epub 2011 Apr 22. Review.


Gabapentin combined with naltrexone for the treatment of alcohol dependence.

Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK.

Am J Psychiatry. 2011 Jul;168(7):709-17. doi: 10.1176/appi.ajp.2011.10101436. Epub 2011 Mar 31.


A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL.

Alcohol Clin Exp Res. 2009 Sep;33(9):1582-8. doi: 10.1111/j.1530-0277.2009.00986.x. Epub 2009 May 26.


Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Mason BJ, Light JM, Williams LD, Drobes DJ.

Addict Biol. 2009 Jan;14(1):73-83. doi: 10.1111/j.1369-1600.2008.00133.x. Epub 2008 Oct 9.


A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.

Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA.

Alcohol Clin Exp Res. 2008 Aug;32(8):1429-38. doi: 10.1111/j.1530-0277.2008.00706.x. Epub 2008 Jun 6.


Cellular and behavioral interactions of gabapentin with alcohol dependence.

Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC, Siggins GR, Koob GF.

J Neurosci. 2008 May 28;28(22):5762-71. doi: 10.1523/JNEUROSCI.0575-08.2008.


The effectiveness of anticonvulsants in psychiatric disorders.

Grunze HC.

Dialogues Clin Neurosci. 2008;10(1):77-89. Review.


Glutamatergic substrates of drug addiction and alcoholism.

Gass JT, Olive MF.

Biochem Pharmacol. 2008 Jan 1;75(1):218-65. Epub 2007 Jun 30. Review.

Supplemental Content

Support Center